Carers have different priorities

Would a drug for dementia that produced modest improvement be worth using, despite side effects? Carers’ views contrast sharply with those of professionals on this question, as Antony Bayer’s research showed.
Author/s: Antony Bayer
Vol: 2, Issue: 1, pp14-15